Literature DB >> 3834064

Inhibitory effects of intravenous chloramphenicol sodium succinate on the disposition of phenylbutazone in horses.

D F Gerken, R A Sams.   

Abstract

The effects of i.v. chloramphenicol sodium succinate on the pharmacokinetics of i.v. phenylbutazone in six healthy adult horses were investigated. Administration of chloramphenicol sodium succinate to mares reduced mean (+/- SD) phenylbutazone clearance from 0.600 +/- 0.222 to 0.339 +/- 0.123 ml/min per kg and increased mean (+/- SD) half life from 244 +/- 59.8 to 371 +/- 80.8 min and mean residence time from 333 +/- 86.2 to 533 +/- 124 min. The mean steady-state volume of distribution of phenylbutazone was unchanged, with mean (+/- SD) values of 187 +/- 28.9 ml/kg in control animals and 170 +/- 32.4 ml/kg after chloramphenicol sodium succinate.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3834064     DOI: 10.1007/bf01059330

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  15 in total

1.  Inhibition of hepatic microsomal enzymes by chloramphenicol.

Authors:  H R Adams; E L Isaacson; B S Masters
Journal:  J Pharmacol Exp Ther       Date:  1977-11       Impact factor: 4.030

2.  Detection of phenylbutazone and oxyphenbutazone in the urine of thoroughbreds.

Authors:  E J Finocchio; F J Ozog; F W Oehme; J H Johnson; G W Osbaldiston
Journal:  J Am Vet Med Assoc       Date:  1970-02-15       Impact factor: 1.936

3.  Prolongation of pentobarbital anesthesia by chloramphenicol in dogs and cats.

Authors:  H R Adams; B N Dixit
Journal:  J Am Vet Med Assoc       Date:  1970-04-01       Impact factor: 1.936

4.  Influence of time interval between administration of chloramphenicol and thiamylal on the sleeping time of mice.

Authors:  A Azadegan; D W Johnson; C M Stowe
Journal:  Am J Vet Res       Date:  1980-06       Impact factor: 1.156

5.  Prolongation of barbiturate anesthesia by chloramphenicol in laboratory animals.

Authors:  H R Adams
Journal:  J Am Vet Med Assoc       Date:  1970-12-01       Impact factor: 1.936

6.  Sequential first-pass elimination of a metabolite derived from a precursor.

Authors:  K S Pang; J R Gillette
Journal:  J Pharmacokinet Biopharm       Date:  1979-06

7.  Plasma and serum concentrations of phenylbutazone and oxyphenbutazone in racing Thoroughbreds 24 hours after treatment with various dosage regimens.

Authors:  L R Soma; R Sams; W Duer; T Tobin; C Woodward; J McDonald
Journal:  Am J Vet Res       Date:  1985-04       Impact factor: 1.156

8.  Drug interactions in the horse: effects of chloramphenicol, quinidine, and oxyphenbutazone on phenylbutazone metabolism.

Authors:  T Tobin; J W Blake; R Valentine
Journal:  Am J Vet Res       Date:  1977-01       Impact factor: 1.156

9.  Pharmacokinetics of chloramphenicol in the neonatal horse.

Authors:  G W Brumbaugh; R J Martens; H D Knight; M T Martin
Journal:  J Vet Pharmacol Ther       Date:  1983-09       Impact factor: 1.786

10.  Effect of chloramphenicol pretreatment on malathion-induced acute toxicity in the rat.

Authors:  R C Gupta; F Welsch; J E Thornburg; B S Paul
Journal:  J Toxicol Environ Health       Date:  1983 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.